Trial Profile
A Phase II Study of the Safety, Efficacy and Pharmacokinetics of VX-710 in Combination With Doxorubicin and Vincristine in Patients With Small Cell Lung Cancer (SCLC)
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2013
Price :
$35
*
At a glance
- Drugs Biricodar (Primary) ; Doxorubicin; Vincristine
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 04 Sep 2005 New trial record.